ArticleActa neuropathologica communications2026
Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF/MEK inhibitors in papillary craniopharyngioma: a report of two cases.
Hirotaka Fudaba et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.